November 2005
Investment Dealers' Digest;11/14/2005, Vol. 71 Issue 43, p40
Trade Publication
The article presents charts and tables depicting investment banking activity and securities trading in the health care industry worldwide as of November 2005. Data for various sectors are included, biotechnology, healthcare equipment, healthcare services, hospitals and pharmaceuticals.


Related Articles

  • Pharma and Biotech: Visions of Outsourced Manufacturing.  // Life Science Today;Dec2001, Vol. 2 Issue 6, p8 

    Reports on developments concerning the pharmaceutical and biotechnology industries as of December 2001. Developments in biotechnology research; Factors influencing the demand for healthcare delivery; Worldwide accessibility of healthcare; Partnership between pharmaceutical industry and...

  • Notes from the field.  // Applied Clinical Trials;Oct2003, Vol. 12 Issue 10, p60 

    Reports on developments related to the medical care in the U.S. as of October 2003. Submission of electronic solution to the U.S. Food and Drug Administration by the biotechnology community; Details of the San Diego, California-based IDEC Pharmaceuticals Corp.'s submission of e-BLA; Tables...

  • Healthcare. Wagley, John // Investment Dealers' Digest;08/21/2000, Vol. 66 Issue 34, p44 

    Presents statistics on the healthcare sector of the securities market worldwide, as of August 17, 2000. Underwriting volume; Debt deals; Equity underwriting calendar; Top new issues managers; Global merger and acquisition deals.

  • CONSULTING SERVICES.  // BioPharm International;Jun2006, Vol. 19 Issue 6, p77 

    The article evaluates Quintiles Consulting's worldwide regulatory, compliance and validation services for the biologics, medical device and pharmaceutical industries.

  • Pharm-Olam International.  // Applied Clinical Trials;Dec2005, Vol. 14 Issue 12, p149 

    This article presents information related to Pharm-Olam International which is a multinational contract research organization. Pharm-Olam International provides comprehensive services to the pharmaceutical, biotechnology and medical device industries. Pharm-Olam International is committed to...

  • Interphex Puerto Rico keeps getting bigger and better. Doyle, B. G. // Caribbean Business;9/27/2012, Vol. 40 Issue 38, p47 

    The article focuses on Interphex Puerto Rico, which celebrates its eight anniversary in 2012. It states that for the last 29 years, the life-sciences company has worked to unite academia, life-sciences entities, and local government to find new growth opportunities and boost the local economy of...

  • Life Sciences and Medical Devices Corporations Operating in Puerto Rico.  // Caribbean Business;11/24/2005, Vol. 33 Issue 46, p21 

    The article presents a map showing the geographical locations of several pharmaceutical, biotechnology and medical devices corporations operating in Puerto Rico in 2005. Among the corporations cited in the article are RD Medical Manufacturing Inc., Eli Lilly and Co. and Alpha Omega Wound Care...

  • Investigative Sites Worldwide Rate ICON as a Top CRO According to Industry Survey.  // Biomedical Market Newsletter;5/9/2011, p628 

    The article reports on Icon PLC, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries rated as a top clinical research organization (CRO) by investigative sites. Peter Gray, chief executive officer (CEO) at Icon PLC states, he is...

  • LSNE Contract Manufacturing.  // Contract Pharma;2012 Corporate Capabilities, Vol. 13 Issue 10, p115 

    The article profiles LSNE Contract Manufacturing, a provider of development, manufacturing, and support services for liquid fill/finish and lyophilized products based in Bedford, New Hampshire which was founded in 1997. It states that LSNE offers commercial supply material to the biotechnology,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics